FTNT's Subscription-Based Services Gain Steam: A Sign of More Upside? — Positive
FTNT Zacks Investment Research — July 10, 2025Fortinet's recurring revenues climb as demand for SASE and SecOps solutions drives its subscription model forward.

Top Stock Movers Now: Delta Air Lines, WK Kellogg, Autodesk, and More — Positive
ADSK DAL KLG Investopedia — July 10, 2025U.S. equities were mostly higher at midday, boosted by optimism in the travel industry. The Dow Jones Industrial Average and S&P 500 were up, while the Nasdaq fell.

MP Materials shares pop on Department of Defense investment — Positive
MP Proactive Investors — July 10, 2025MP Materials (NYSE:MP) shares surged almost 50% after it revealed the Pentagon has become its largest shareholder in a bid to boost the domestic supply of rare earth minerals. The US Department of Defense (DoD) has invested $400 million in MP Minerals' preferred stock, giving it a roughly 15% stake in the company.

RYTM Stock Rises on Upbeat Acquired Hypothalamic Obesity Study Data — Positive
RYTM Zacks Investment Research — July 10, 2025Rhythm Pharmaceuticals jumps 36.6% after its oral drug bivamelagon shows strong BMI and hunger reductions in a phase II study in acquired hypothalamic obesity.

Canadian Red Cross and Walmart Canada launch annual giving campaign — Neutral
WMT GlobeNewsWire — July 10, 2025Funds raised support disaster relief in communities across the country Funds raised support disaster relief in communities across the country

The iShares Treasury Floating Rate Bond ETF (TFLO) offers exposure to US Treasury FRNs, providing low credit risk and automatic coupon adjustments with interest rate changes. TFLO is best used as a hedge against rising rates or as a 'cash plus' alternative, but current macro conditions do not favor new purchases. Imminent interest rate cuts and stable credit spreads reduce the fund's attractiveness, as future returns are likely to decline with lower SOFR rates.

FRT Buys Kansas Retail Centers, Aims at Portfolio Quality Enhancement — Positive
FRT Zacks Investment Research — July 10, 2025FRT revamps its portfolio with retail buys in Kansas, asset sales in Los Angeles and new housing build in Santana Row.

Elastic Recognized as a Leader in 2025 Gartner® Magic Quadrant™ for Observability Platforms — Neutral
ESTC Business Wire — July 10, 2025SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI Company, announced it has been positioned by Gartner as a Leader in the Magic Quadrant for Observability Platforms for its offering, Elastic Observability. The evaluation was based on specific criteria that analyzed the company's overall Completeness of Vision and Ability to Execute. “Visibility alone isn't enough; customers need rapid context-rich insights to troubleshoot complex systems,” said Santosh Krishnan, general manage.

Byrna Technologies Inc. (BYRN) Q2 2025 Earnings Call Transcript — Neutral
BYRN Seeking Alpha — July 10, 2025Byrna Technologies Inc. (NASDAQ:BYRN ) Q2 2025 Earnings Conference Call July 10, 2025 9:00 AM ET Company Participants Bryan Scott Ganz - CEO, President & Director Laurilee Kearnes - CFO & Treasurer Conference Call Participants Jeffrey Wallin Van Sinderen - B. Riley Securities, Inc., Research Division Jon Robert Hickman - Ladenburg Thalmann & Co. Inc., Research Division Matthew Butler Koranda - ROTH Capital Partners, LLC, Research Division Operator Good morning.

Oracle Stock Upgrade On AI Surge, OpenAI Deal Seen Fueling Growth — Positive
ORCL Benzinga — July 10, 2025Oracle Corp ORCL is poised to benefit from rising enterprise demand for AI infrastructure, according to Piper Sandler.

Transaction in Own Shares 10 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 10 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 10/07/2025 443,503 £26.6500 £26.2500 £26.5120 LSE GBP 10/07/2025 149,501 £26.6500 £26.2550 £26.5179 Chi-X (CXE) GBP 10/07/2025 86,996 £26.6500 £26.2550 £26.5317 BATS (BXE) GBP 10/07/2025 392,780 €31.0000 €30.5150 …

STNE Stock Rises 108% Year to Date: Still a Buy or Time to Wait? — Positive
STNE Zacks Investment Research — July 10, 2025STNE surges 108% YTD, fueled by strong fintech momentum, disciplined growth and rising investor confidence.

Jobless Claims Tick in Lower.

Can Trade Desk Sustain Double-Digit Revenue Growth Amid Headwinds? — Neutral
TTD Zacks Investment Research — July 10, 2025TTD expects Q2 revenues to rise 17% YoY, with AI adoption and CTV gains offsetting macro headwinds and rising costs.

Credo's revenue and EPS growth are impressive, with margins expanding and Q1 guidance pointing to even stronger results ahead. Management is actively diversifying the customer base, reducing Amazon dependency and mitigating key business risks. Despite a high P/S ratio, I believe Credo's exceptional growth and industry leadership justify the premium valuation.

Gold remains well supported above $3,300 through 2025 - Metals Focus — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — July 10, 2025Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

DoorDash hits Seattle with increased service fees, blames new city regulations — Negative
DASH Fox Business — July 10, 2025Seattle customers face higher DoorDash service fees as the company reports operating at a loss in 2024 despite $10.7 billion in revenue due to strict local regulations.

REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy — Neutral
RGNX PRNewsWire — July 10, 2025Construct including CT domain demonstrated higher levels of microdystrophin protein, increased muscle force, and improved resistance to damage in mice lacking dystrophin REGENXBIO's next-generation investigational gene therapy, RGX-202, is the only microdystrophin construct that includes the CT domain Findings support the positive functional data seen in Phase I/II AFFINITY DUCHENNE® trial of RGX-202 ROCKVILLE, Md. , July 10, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the publication of preclinical results comparing a microdystrophin gene therapy construct that included the C-terminal (CT) domain to a microdystrophin construct without the CT domain.

MBNKO: A 9% Fixed Rate Reset Preferred Share IPO From Medallion Financial — Neutral
MFIN Seeking Alpha — July 10, 2025Medallion Financial Corp.'s new 9% preferred, MBNKO, offers high yield but comes with substantial credit risk. Medallion Financial's high leverage, weak capital structure, and inconsistent dividend history raise red flags for preferred shareholders. Relative to peers, MBNKO's risk/reward profile is unattractive for me, with a below Single-B implied credit quality and longer duration.
